Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479
https://ir.nurixtx.com/news-releases/news-release-details/gilead-exercises-option-license-nurixs-irak4-targeted-protein
© 2022 Regents of the University of California. All Rights Reserved.